Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NOP56 ribonucleoprotein pseudogene 2 (NOP56P2) is a human pseudogene, meaning it is a DNA sequence that resembles a known functional gene (NOP56) but does not encode a functional protein product[4][2]. Pseudogenes can arise through duplication or retrotransposition events and typically have disabling mutations that prevent normal gene expression or protein function[2][4]. There is no evidence that NOP56P2 functions as a therapeutic target, nor does it have established roles in disease, drug interactions, or biomarker applications. It should not be confused with the functional gene NOP56 ribonucleoprotein, which is involved in ribosome biogenesis and is itself a validated biological target in some contexts[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NOP56 ribonucleoprotein pseudogene 2 (NOP56P2).